R-roscovitine
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
a drug that targets cell cycle proteins could protect the brain from injury after stroke, according to new research conducted in…
Seliciclib (R-roscovitine, CYC202) is a small molecule inhibitor of cyclin-dependent kinases currently in phase II clinical…
R-roscovitine (seliciclib, CYC202) is a cyclin-dependent kinase inhibitor currently in phase II clinical trials in patients with…
Vascular endothelial growth factor (VEGF) regulates vascular permeability and endothelial cell proliferation. In the rat anti…
Toward the goal of developing effective treatments for prostate cancers, we examined the effects of cyclin-dependent kinase…